MoneyWorks4Me

Cipla informs about analyst meet

07 Jun 2021 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it has enclosed the schedule of Analyst / Institutional Investor Meetings with the Company. The schedule of this meeting is subject to change and the change may occur due to exigencies on the part of Investor / Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..